Tarsus to Present at the Jefferies 2022 Healthcare Conference
May 27, 2022 09:00 ET | Tarsus Pharmaceuticals, Inc
IRVINE, Calif., May 27, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize...
Northrim BanCorp, Inc. new logo
Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.41 per Share
May 27, 2022 09:00 ET | Northrim BanCorp Inc
ANCHORAGE, Alaska, May 27, 2022 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ: NRIM) today announced that the Board of Directors declared a regular quarterly cash dividend of $0.41 per share....
CORRECTING and REPLACING - Hepion Pharmaceuticals, Inc.
May 27, 2022 08:54 ET | Hepion Pharmaceuticals, Inc.
EDISON, N.J., May 27, 2022 (GLOBE NEWSWIRE) -- In the press release issued earlier today by Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), we've been informed by the company that in both the headline...
Navitas: World’s First CarbonNeutral®-Certified Semiconductor Company
May 27, 2022 08:30 ET | Navitas Semiconductor Corporation
Advances mission to “Electrify Our World™” as each next-gen GaN power IC saves 4 kg CO2 EL SEGUNDO, Calif., May 27, 2022 (GLOBE NEWSWIRE) -- Navitas Semiconductor, industry-leader in GaN power ICs,...
Manhattan Associates Announces its Customer Award Winners at Momentum 2022
May 27, 2022 08:30 ET | Manhattan Associates, Inc.
ATLANTA, May 27, 2022 (GLOBE NEWSWIRE) -- Manhattan Associates Inc. (NASDAQ: MANH) has announced the winners of the 2022 Spotlight on Innovation Awards, presented at Momentum 2022, the company’s...
Dentsply Sirona Declares Quarterly Cash Dividend
May 27, 2022 08:00 ET | DENTSPLY SIRONA Inc.
CHARLOTTE, N.C., May 27, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), announced that its Board of Directors declared a quarterly cash dividend of $0.125 per...
new logo.jpg
Immutep Announces Publication of TACTI-002 and TACTI-003 Abstracts at ASCO 2022
May 27, 2022 08:00 ET | Immutep Limited
Efti in combination with pembrolizumab continues to show favourable antitumor activity in 1st line non-small cell lung cancer (NSCLC) patients from TACTI-002 with data cut off January 2022Improved...
PDC Energy Announces its Updated 2022 Guidance and Multi-Year Outlook, Raises its Free Cash Flow and Return of Capital Projections
May 27, 2022 08:00 ET | PDC Energy, Inc.
DENVER, May 27, 2022 (GLOBE NEWSWIRE) -- PDC Energy, Inc. (“PDC” or the “Company”) (Nasdaq:PDCE) today provided its updated 2022 guidance after closing the Great Western Petroleum acquisition...
Bolt Biotherapeutics to Present Ex Vivo Data Characterizing the Myeloid Cell Landscape in Solid Tumors at ASCO 2022
May 27, 2022 08:00 ET | Bolt Biotherapeutics, Inc.
- Ex vivo data support the high frequency of myeloid cells in tumors, even when T cells are not present - REDWOOD CITY, Calif., May 27, 2022 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq:...
cdkglobal_wm_blk_New Logo.jpg
CDK Global, Inc. Announces Extension of the Expiration Date of Its Tender Offers and Consent Solicitations
May 27, 2022 08:00 ET | CDK Global, Inc.
HOFFMAN ESTATES, Ill., May 27, 2022 (GLOBE NEWSWIRE) -- CDK Global, Inc. (Nasdaq: CDK) (“CDK” or the “Company”), a leading automotive retail technology company, today announced that it is extending...